Should I buy American Healthcare REIT (AHR) stock or is it too late?
⭐ The most reliable of them, either direction: Compass Point — 61% of its targets hit on this sector (23 calls tested). It aims for $70 (+24 %), call made on July 22, 2026, maturing on July 22, 2027 (37 d ago).
Firm-by-firm track record on American Healthcare REIT
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JMP Securities | 100 % | +101.3 % | 6 | $50 -11% |
| Truist Securities | 100 % | +82.5 % | 11 | $61 +8% |
| Morgan Stanley | 100 % | +80.5 % | 5 | $55 -3% |
| Keybanc | 100 % | +68.7 % | 5 | $68 +20% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $63, i.e. +12% from the current price ($56).
- Pays a dividend (1.9% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- Even the most reliable firm on AHR, JMP Securities (100% hit rate, 6 scored calls), only targets $50 (call made on October 17, 2025, maturing on October 17, 2026) (-11%) in its most recent call. The stock may already have run past its target.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on AHR
Median target $63 (+12%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in American Healthcare REIT now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $63 (+12%), and JMP Securities (most reliable on AHR, 100%) targets $50. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in American Healthcare REIT?
Not according to analysts: the median target ($63) is still +12% above the current price ($56) (most reliable on AHR: JMP Securities, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is American Healthcare REIT still worth investing in?
It depends on the gap between the price ($56) and its estimated value: analysts target $63 on median (+12%), with 100% buys (most reliable on AHR: JMP Securities, 100%). Cross-check with their real reliability on AHR and the cautions above. Information, not advice.
What's the main risk in buying AHR?
Even the most reliable firm on AHR, JMP Securities (100% hit rate, 6 scored calls), only targets $50 (call made on October 17, 2025, maturing on October 17, 2026) (-11%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full American Healthcare REIT profile (consensus, analyst reliability, price target, performance).